Compare Oatly Group AB - ADR (OTLY) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oatly Group AB - ADR vs Tenet Healthcare Corporation — how do they compare? Oatly Group AB - ADR trades at $11.93 (market cap $330.93M), while Tenet Healthcare Corporation trades at $260 (market cap $20.92B). The key difference: Tenet Healthcare Corporation is far larger — about 63.2× Oatly Group AB - ADR's market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, Oatly Group AB - ADR nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Oatly Group AB - ADR for 18 Days and Tenet Healthcare Corporation for 15 Days on average.
| OTLY | THC | |
|---|---|---|
Market Cap | $330.93M | $20.92B |
Volume | 44,023 | 455,764 |
Sector | Consumer Staples | Health |
52-Week High | $15.91 | $280.77 |
52-Week Low | $8.03 | $161.37 |
Typical Hold Time | 18 Days | 15 Days |
Enterprise Value | $835.34M | $32.00B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Oatly (OTLY) trades at $10.38, down 1.24% today, with a mixed technical picture showing bearish moving averages but oversold RSI levels. The company continues to report revenue growth ($862M in 2025) but remains unprofitable with a -17.72% net margin. Recent Q2 2026 results showed a revenue beat and improved guidance, driving positive sentiment. Analyst consensus is divided with a $12.28 price target, while cash flow trends show gradual operational improvement despite negative net income.
The outlook remains challenging as Oatly works toward profitability amid high debt levels and negative cash flow. Investment opportunity exists if margin improvements continue and the company achieves positive EBITDA. Key risks include execution on cost controls, competitive pressures in plant-based beverages, and the sustainability of recent revenue growth momentum in a challenging consumer environment.
Tenet Healthcare (THC) trades at $259.83, up 0.53% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with consistent earnings beats (Q4 2025-Q2 2026), 82.83% gross margins, and 53.31% ROE. Recent news highlights strong cash flow supporting capital returns, with Q3 2026 results expected October 29, 2026.
THC presents compelling value with a 10.04 P/E ratio and 81.25% analyst buy ratings. Upside potential to $283.36 consensus target exists, though negative cash flow trends and insider selling warrant monitoring. The stock's premium valuation (P/B 4.49) requires sustained execution amid healthcare sector volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Oatly Group AB - ADR
Oatly Group AB is engaged in the food and drinks industry. Some of its products include Oat Drink, Chilled Oat Drink, Oatgurt, Creamy Oat, Icecreams, among others. It caters to Sweden, Germany, United Kingdom, Netherlands, North America, Finland, and other markets.
Read more on OTLY →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
